skc
Goldmember
- Joined
- 12 August 2008
- Posts
- 8,277
- Reactions
- 329
That will lower EBITDA because of changes in WIP but improve OCF as that WIP is liquidated. Call me cynical, but because SGH have guidance that excludes WIP (ie EBITDAW) this won't flow through to that number, but the positive affect on OCF will, to the tune of about $42m at today's fx rate.
The positive side of this is that they do appear to be trying to rein in working capital.
I think the selloff today probably has more to do with the negative OCF forecast in the first period, and the heavier weighting toward the second half.
Been thinking about this a bit more. SGH has now owned QPP/PSD/SGS for 5 months now... so they know a lot better what they actually acquired. The acquisition included 3 major assets...
1. A huge amount of in-progress cases.
2. Existing staff
3. Existing business processes and relationships.
From the AGM update, there are hints that 1 and 3 are severely impaired. The reduction in WIP growth, originally stated growth to 95k cases in FY16 (from 83.5k in FY15), will now be down to ~73k (of which 6k due to Swinton, which was supposed to be immaterial). The reason given is that they will stop taking in cases that occurred over 12 months ago as they have poor resolution rate.
How many cases did SGH actually acquire from QPP (I couldn't find the number)? What is the average age of those cases (I don't think it was disclosed)? Given that QPP has had poor cashflow, you'd think they would have targeted those low hanging fruits quickly, while building up an increasing amount of stale cases. Makes you wonder how representative are those 8000 "due diligence" cases that SGH undertook before the acquisition. Does SGH keep spending cash on hoping they will be resolved? Or should they just bite the bullet and walk away from them (Are they legally allowed to do that)? My guess is there'd be some writedown coming.
Before introduction of the new EBITDAW measures, PSD was supposed to earn GBP 95m in FY16. The change in case intake reduced the number by 20m. So that's a big downgrade regardless of the troubles of their EBITDA definition.
Good thing that they didn't pay anything for the NIHL cases - so at leaset there won't be any writedowns. But my guess is that they are also bleeding there for the same rationale. They have 360 staff working on these and each wants to be paid monthly regardless of case resolution rates. And btw, hearing loss cases are most definitely a lot older than 12 months.
To make matters worse, SGH's own UK business (non-QPP part) is also off to a slow start. It's not possible to tell what proportion of the negative $30-40m cashflow stems from SGS vs SGH UK... but the timing couldn't be much worse. This is particularly worrying because it coincided with regulatory review and recent process changes. It's too early to tell when things will turnaround.
This is a passage from another article. http://www.legalfutures.co.uk/lates...-ex-quindell-business-to-improve-pi-win-rates
Mr Grech said the firm has taken “important strides in charting a clear direction for [SGS], which is markedly different from how it was run by its previous owners”.
He explained: “In multiple areas, we are seeking to reset relationships with counterparties, including insurers, business introducers and suppliers, in line with [our] corporate values.”
This reads to me that everything they acquired in terms of business relationships were unworkable.
Anyhow... the worst part of the AGM address was probably this.
Given the slower than expected start to the year in the UK business and the risk that we may not be able to recover the lost ground by 31 December there is now a likelihood that Group operating cash flow will be negative in the range of A$30-40 million in the first half, with a strong recovery expected in the second half. We are taking a range of actions to mitigate this risk and we are confident that we will achieve our financial year guidance and that we will remain in compliance with our obligations to financiers.
That's a throwaway line that's really highlighting how stretched SGH's cash situation might be. That's not a line that you need to include if you are confident of a turnaround, or that the negative performance is only transient.
So to me there are enough hints in this AGM to suggested that SGH acquired something hairy, yellow, that may or may not smell like a lemon. It will take another period to confirm what fruit it actually is. SGH may be so talented that it may be able to eventually turn it all around. They can write off Asset 1, retain/improve Asset 2 and rebuild Asset 3. But this probably will only happen over the very long term (3+ years) and probably with an unpleasant near-death experience in between.
Let's see how the market judge SGH on Monday after digesting the news over the weekend. Some massive Day 2+ moves after AGMs of late.